Related Experiment Video
Updated: Sep 12, 2025

Tissue Engineering of the Intestine in a Murine Model
Published on: December 1, 2012
Incidence of chronic intestinal failure due short bowel syndrome in adults: A feasibility study
Loris Pironi1, Federica Sacilotto2, Simona Sasdelli2
1Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; Centre for Chronic Intestinal Failure, IRCCS AOUBO, Bologna, Italy.
Background:
The incidence of short bowel syndrome associated chronic intestinal failure (SBS-CIF) is entirely unknown. A feasibility study was carried out in the tertiary-level hospital of the Bologna University (Italy), to test a protocol devised to investigate the in-hospital and the population incidences of SBS-CIF.
Methods:
A 3-month (January-March 2024) retrospective survey was carried out in the two digestive disease surgical units of the hospital. Patient inclusion criteria were: age ≥18 years, abdominal surgery with small bowel resection and no-home parenteral nutrition (HPN) before hospital admission. Exclusion criterion: patient already on HPN at hospital admission. Criterion for the diagnosis of "SBS-CIF" was patient discharge on HPN within 3 months from inclusion of the study (end of the follow-up, June 30th 2024). The 3-month in-hospital and population incidences were calculated as percentage of patients who underwent abdominal surgery with a small bowel resection procedure and who developed SBS-CIF, and as "SBS-CIF" per million of inhabitants of the Bologna metropolitan area, respectivelyy.
Results:
Sixty-seven patients met the inclusion criteria. At June 30th, 56 patients were discharged without HPN (83.5 %), 5 died during hospitalization, 6 were discharged on HPN (in-hospital incidence SBS-CIF: 8.9 %). Two SBS-CIF were resident in the Bologna metropolitan area (SBS-CIF incidence: 1.96 cases/106 inhabitants).
Conclusions:
Our study proposes a model to investigate the incidence of SBS-CIF in adults. The results provide new data on this hitherto unexplored area of SBS-CIF epidemiology and, importantly, offer a model for multicenter studies to further investigate the epidemiology of SBS-CIF on a national and international scale.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:

